Splice-switching therapy with splice-switching oligonucleotides (SSOs) has recently proven to be a clinically applicable strategy for the treatment of several mis-splice disorders. Despite this, wider application of SSOs is severely limited by the inherently poor bioavailability of SSO-based therapeutic compounds. Cell-penetrating peptides (CPPs) are a class of drug delivery systems (DDSs) that have recently gained considerable attention for improving the uptake of various oligonucleotide (ON)-based compounds, including SSOs. One strategy that has been successfully applied to develop effective CPP vectors is the introduction of various lipid modifications into the peptide. Here, we repurpose hydrocarbon-modified amino acids used in peptide ...
CPPs (cell-penetrating peptides) have given rise to much interest for the delivery of biomolecules s...
A drug delivery system designed specifically for oligonucleotide therapeutics can ameliorate the pro...
Thesis: Ph. D. in Biological Chemistry, Massachusetts Institute of Technology, Department of Chemist...
The hydrophobic plasma membrane constitutes an indispensable barrier for cells, allowing influx of e...
Modifying cell-penetrating peptides (CPPs) with fatty acids has long been used to improve peptide-me...
Aberrations in splicing patterns play a significant role in several diseases, and splice correction,...
Oligonucleotide-based drugs hold great promise for the treatment of many types of diseases, ranging ...
Gene therapy holds the promise of revolutionizing the way we treat diseases. By using recombinant DN...
The plasma membrane functions as a barrier, restricting entry of hydrophilic pharmaceutical agents. ...
Concerns associated with nanocarriersâEurotm therapeutic efficacy and side effects have led to the d...
High molecular weight biomolecules are becoming important in the development of new therapeutics. Ho...
International audienceCell-penetrating peptides (CPPs) are short sequences often rich in cationic re...
Developing efficient delivery vectors for bioactive molecules is of great importance within both tra...
Our genome operates by sending instructions, conveyed by mRNA, for the manufacture of proteins from ...
Numerous human genetic diseases are caused by mutations that give rise to aberrant alternative splic...
CPPs (cell-penetrating peptides) have given rise to much interest for the delivery of biomolecules s...
A drug delivery system designed specifically for oligonucleotide therapeutics can ameliorate the pro...
Thesis: Ph. D. in Biological Chemistry, Massachusetts Institute of Technology, Department of Chemist...
The hydrophobic plasma membrane constitutes an indispensable barrier for cells, allowing influx of e...
Modifying cell-penetrating peptides (CPPs) with fatty acids has long been used to improve peptide-me...
Aberrations in splicing patterns play a significant role in several diseases, and splice correction,...
Oligonucleotide-based drugs hold great promise for the treatment of many types of diseases, ranging ...
Gene therapy holds the promise of revolutionizing the way we treat diseases. By using recombinant DN...
The plasma membrane functions as a barrier, restricting entry of hydrophilic pharmaceutical agents. ...
Concerns associated with nanocarriersâEurotm therapeutic efficacy and side effects have led to the d...
High molecular weight biomolecules are becoming important in the development of new therapeutics. Ho...
International audienceCell-penetrating peptides (CPPs) are short sequences often rich in cationic re...
Developing efficient delivery vectors for bioactive molecules is of great importance within both tra...
Our genome operates by sending instructions, conveyed by mRNA, for the manufacture of proteins from ...
Numerous human genetic diseases are caused by mutations that give rise to aberrant alternative splic...
CPPs (cell-penetrating peptides) have given rise to much interest for the delivery of biomolecules s...
A drug delivery system designed specifically for oligonucleotide therapeutics can ameliorate the pro...
Thesis: Ph. D. in Biological Chemistry, Massachusetts Institute of Technology, Department of Chemist...